Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.64
Delayed Data
As of 3:14pm ET
 -0.16 / -2.35%
Today’s Change
5.85
Today|||52-Week Range
11.69
-4.32%
Year-to-Date
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals
Feb 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close6.80
Today’s open6.96
Day’s range6.64 - 6.80
Volume331,953
Average volume (3 months)974,408
Market cap$503.6M
Dividend yield--
Data as of 3:14pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...-0.68-3.01%
SCLNSciClone Pharmaceuti...-0.07-0.75%
RETAReata Pharmaceutical...-0.04-0.17%
OMEROmeros Corp+0.17+1.48%
Data as of 3:26pm ET, 02/22/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts


Search for Jobs